Midstream Collection Kits Market: Current Analysis and Forecast (2022-2028)

The midstream collection kits market is expected to register a CAGR of approx. 5% over the period of 2022-2028. Midstream collection kits are widely used for urine collection and storage. The majority of other tests carried out in order to run a physical test are less accurate than specimen tests. An essential component of first-line diagnosis is the examination of urine samples taken from the hospital or home-based patients. It is therefore critical to obtain the specimen effectively and easily in order to perform the test. Regardless of a patient's gender or appearance, midstream collection kits are suitable for nearly all patient categories. The growing demand for midstream collection kits can be attributed due to the rising incidence of diseases such as Urinary Tract Infections (UTIs) which boosts the adoption of organic growth strategies among key industry players around the globe. For instance, According to The National Center for Biotechnology Information, globally, around 6 million people are diagnosed with urinary tract infections every year. Owing to the glaring statistics the rising prevalence of UTI boosts the demand for midstream collection kits across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the midstream collection kits market is anticipated to grow on account of the increasing number of diagnostic procedures. In addition, the rising prevalence of kidney diseases is anticipated to increase demand for products that are used in urinalysis driving market growth. However, some of the restraints in the market including the alternative approaches to diagnosis and lack of trained professionals are impeding the growth of this market all over the world.

Based on the test type, the midstream collection kits market is segmented into urine test kits, ovulation predictor test kits, HIV test kits, pregnancy tests, and others. The pregnancy tests segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. Increasing awareness with regard to the latest pregnancy detection kits, rising knowledge about how to use self-detecting pregnancy devices and their benefits, and the surging preference for self-detecting kits boost the segment of the market.

Based on the distribution channel, the market is fragmented into hospital pharmacy, retail pharmacy, and e-commerce. The hospital pharmacy segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the purpose of quickly conducting a test. The midstream collection kits are designed to be used in home-care settings as well, with immediate response to the test available in R&D laboratories.

For a better understanding of the market adoption of the midstream collection kits, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. Asia Pacific constitutes a major market for the midstream collection kits industry owing to the presence of prominent players in the region. Furthermore, the unique strategies adopted by manufacturers, as well as targeting methods to include lab testing with the help of midstream collection kits, are bolstering the regional market's growth.

Some of the major players operating in Thermo Fisher Scientific Inc, Medline Industries, Cardinal Health Inc, PRETIUM PACKAGING, Medisave UK Ltd, Becton Dickinson and Co, Oscar Medicare Pvt Ltd among others. Several M&A's along with partnerships have been undertaken.